{
    "nct_id": "NCT04589468",
    "official_title": "Phase 1a/b Trial of Exercise as Interception Therapy for Primary High-Risk Cancer",
    "inclusion_criteria": "* Postsurgical diagnosis of patients with primary solid tumors at high-risk of relapse as defined by one of the following:\n\n  ° High-risk primary solid tumor (e.g., colorectal, ovarian, non-small cell lung cancer) (colorectal cancer only for Phase 1a)\n* Stage 3 or\n* ctDNA positive\n\n  ° High-risk breast cancer\n* Residual invasive disease in the breast or the lymph nodes following completion of neoadjuvant chemotherapy (NACT),\n* Estrogen receptor (ER), and/or progesterone receptor (PR) positive and HER2 negative,\n* CPS-EG score ≥ 3,\n* CPS-EG score ≥2 w ith ypN+, or\n* Recurrence score ≥ 25\n* No evidence of disease\n* Age ≥ 18\n* Interval of ≥ 1 month but ≤ 2 years following completion of all definitive adjuvant therapy\n* Non-exercising (i.e., < 30 minutes of moderate and < 20 mins of vigorous exercise/wk), as assessed by remote activity and heart rate tracking for a 7-day period prior to study entry)\n\n  ° If ≥ 30 minutes but less than 45 minutes of moderate exercise/week, or if ≥ 20 minutes but less than 30 minutes of vigorous exercise/week, patients may be eligible, at the discretion of the PI.\n* Cleared for exercise participation as per screening clearance via PAR-Q+\n* Willingness to comply with all study-related procedures\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Enrollment onto any other interventional investigational study except interventions determined by the PI not to confound study outcomes\n* Any other current diagnosis of invasive cancer of any kind\n* Distant metastatic malignancy of any kind\n* Any other condition or intercurrent illness that, in the opinion of the investigator, makes the subject a poor candidate for study participation",
    "miscellaneous_criteria": ""
}